As MPO accumulates into the coronary endothelium in CAD patients and MI survivors [96], a further therapeutic option is the removal of endothelial-sequestered MPO from the coronary endothelium back into the circulation with heparins [228]. The gene discussed is MPO; the disease is myocardial infarction.